AstraZeneca rejects German reports questioning efficacy of the vaccine
Pharma giant AstraZeneca has defended the efficacy of its Covid-19 vaccine after media reports said the German government had doubts about its effectiveness among those over 65.
Handelsblatt had reported on Monday that Berlin had estimated that the efficacy of the jab in people above 65 was just 8%, citing unnamed sources. Separately Bild daily, quoting anonymous sources, put the efficacy rate at “less than 10%.
A suspicious package at an AstraZeneca COVID-19 vaccine plant in Wales which forced a temporary suspension of manufacturing has been made safe and production schedules of the shots have not been affected, the company Wockhardt UK said on Wednesday.
“Upon expert advice, we have partially evacuated the site pending a full investigation. The safety of our employees and business continuity remain of paramount importance,” the company said in a statement.